Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash from operating activities | -126.52%-362K | 136.41%2.49M | -124.98%-2.61M | 576.32%8.43M | -49.12%3.43M | 140.01%1.37M | -2,254.14%-6.83M | 685.83%10.46M | 130.80%1.25M | 555.62%6.73M |
| Net profit before non-cash adjustment | 278.50%739K | 53.52%-660K | 79.92%-919K | 92.12%-3.61M | 109.74%2.8M | 91.10%-414K | 59.82%-1.42M | 48.81%-4.58M | 72.67%-45.84M | 80.03%-28.72M |
| Total adjustment of non-cash items | 38.17%3.01M | -36.65%3.18M | 20.08%3.12M | -65.89%12.6M | -89.61%2.8M | -11.56%2.18M | 27.83%5.02M | -27.33%2.6M | -73.67%36.94M | -79.13%26.97M |
| -Depreciation and amortization | ---- | ---- | 37.88%3.12M | -10.18%12.45M | ---- | ---- | ---- | -35.22%2.26M | -15.83%13.87M | ---- |
| -Reversal of impairment losses recognized in profit and loss | ---- | ---- | ---- | -111.15%-2.28M | ---- | ---- | ---- | ---- | -83.44%20.42M | ---- |
| -Disposal profit | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | 86.47%-321K | ---- |
| -Net exchange gains and losses | ---- | ---- | ---- | -1.19%1.25M | ---- | ---- | ---- | ---- | 7,111.11%1.26M | ---- |
| -Other non-cash items | 38.17%3.01M | ---- | ---- | -31.43%1.17M | -4.48%-8.62M | -11.56%2.18M | 2.59%7.28M | -16.67%335K | -41.35%1.71M | -2,248.96%-8.25M |
| Changes in working capital | -925.69%-4.11M | 99.66%-35K | -138.66%-4.81M | -105.52%-560K | -125.65%-2.18M | 67.32%-401K | -1,424.56%-10.43M | 247.40%12.44M | -56.59%10.15M | -35.16%8.48M |
| -Change in receivables | ---- | ---- | ---- | -176.30%-4.39M | ---- | ---- | ---- | -42.15%2.57M | -74.85%5.75M | ---- |
| -Change in inventory | ---- | ---- | ---- | -53.93%1.92M | ---- | ---- | ---- | 317.34%1.77M | 220.80%4.16M | ---- |
| -Change in payables | ---- | ---- | ---- | 700.42%1.91M | ---- | ---- | ---- | 15,390.57%8.1M | -93.95%239K | ---- |
| -Changes in other current assets | 47.34%-1.9M | -502.67%-4.74M | -165.14%-2.83M | -109.07%-899K | -107.54%-841K | -5.37%-3.61M | ---786K | --4.34M | --9.91M | --11.15M |
| -Changes in other current liabilities | -168.86%-2.21M | 148.77%4.7M | -124.48%-1.98M | -1,700.84%-3.83M | -105.96%-5.5M | 45.89%3.21M | ---9.64M | --8.1M | --239K | ---2.67M |
| Dividends paid (cash flow from operating activities) | ||||||||||
| Dividends received (cash flow from operating activities) | ||||||||||
| Interest paid (cash flow from operating activities) | 0 | -39.20%771K | 62.96%-170K | 34.64%-266K | 16.67%-335K | 0 | 1.27M | |||
| Interest received (cash flow from operating activities) | 285K | 246K | -27.16%244K | 0 | 335K | 0 | ||||
| Tax refund paid | ||||||||||
| Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating cash flow | -106.44%-77K | 135.19%2.73M | -121.95%-2.37M | 576.32%8.43M | -47.55%4.2M | 130.87%1.2M | -1,013.77%-7.76M | 593.51%10.8M | 130.80%1.25M | 656.33%8M |
| Investing cash flow | ||||||||||
| Net PPE purchase and sale | 99.91%-1K | ---99K | --0 | -1,962.26%-1.09M | --27K | ---1.12M | --0 | --0 | 71.51%-53K | --0 |
| Investing cash flow | 99.02%-11K | ---99K | --0 | -1,962.26%-1.09M | --27K | ---1.12M | --0 | --0 | -100.30%-53K | --0 |
| Financing cash flow | ||||||||||
| Net issuance payments of debt | -14.00%-228K | 24.79%-452K | 95.00%-250K | 29.90%-2.87M | 203.14%2.93M | 21.26%-200K | 19.97%-601K | -1,837.60%-5M | -455.90%-4.1M | -166.38%-2.84M |
| Net common stock issuance | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- | -34.67%780K | --0 |
| Increase or decrease of lease financing | ---- | ---- | ---- | ---489K | ---- | ---- | ---- | ---- | --0 | ---- |
| Interest paid (cash flow from financing activities) | ---285K | -173.43%-246K | 27.16%-244K | 31.43%-1.17M | ---1.17M | --0 | --335K | ---335K | 41.37%-1.71M | ---- |
| Net other fund-raising expenses | -98.19%8K | -99.15%6K | -19.85%1.78M | ---6K | ---3.37M | --442K | --709K | --2.22M | ---- | ---- |
| Financing cash flow | -308.68%-505K | -256.21%-692K | 141.16%1.28M | 9.72%-4.54M | 53.59%-2.11M | -53.99%242K | 158.99%443K | -1,108.14%-3.12M | -5,553.93%-5.03M | -249.98%-4.55M |
| Net cash flow | ||||||||||
| Beginning cash position | 333.87%3.51M | 170.37%1.68M | 495.92%2.78M | -80.01%446K | 49.27%1.12M | 177.05%809K | -53.03%621K | -79.11%466K | 124.01%2.23M | -42.25%753K |
| Current changes in cash | -287.07%-593K | 126.52%1.94M | -114.15%-1.09M | 172.70%2.79M | -38.81%2.11M | 109.48%317K | -404.83%-7.32M | 407.61%7.68M | -128.13%-3.84M | -3.98%3.45M |
| Effect of exchange rate changes | 1,500.00%28K | -101.47%-110K | 99.85%-11K | -122.40%-460K | 87.77%-460K | -100.05%-2K | 1,687.62%7.51M | -572.67%-7.51M | 196.80%2.05M | -40.88%-3.76M |
| Cash adjustments other than cash changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---20K | ---- | ---- |
| End cash Position | 162.01%2.95M | 333.87%3.51M | 170.37%1.68M | 522.65%2.78M | 522.65%2.78M | 49.27%1.12M | 177.05%809K | -53.03%621K | -80.01%446K | -80.01%446K |
| Free cash flow | -204.00%-78K | 133.92%2.63M | -121.95%-2.37M | 514.75%7.33M | -47.21%4.22M | 101.94%75K | -1,010.59%-7.76M | 582.27%10.8M | 128.20%1.19M | 625.48%8M |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.